Fetuin B Activation – Limb Regeneration
Understanding Limb Regeneration
and Fetuin B
Limb regeneration is one of the most remarkable abilities in nature, seen in certain amphibians like salamanders, but largely absent in humans and other mammals. After amputation or severe injury, humans typically form scar tissue instead of regenerating complex structures such as muscle, bone, nerves, and blood vessels.
Fetuin B is a protein that plays a significant role in regulating tissue remodeling, inflammation control, and cellular differentiation. Emerging research suggests that Fetuin B is involved in pathways that support tissue repair and may influence regenerative processes. We believe that activating Fetuin B could help shift the default healing response from scarring toward true tissue regeneration, potentially opening the door to regrowing limbs or large tissue sections in humans.
This approach represents a bold frontier in regenerative medicine, aiming to unlock latent regenerative capacity in mammalian tissues.
The Role of Fetuin B Activation
Activating Fetuin B may promote:
+
Enhanced tissue remodeling and repair
+ Reduced excessive scarring (fibrosis)
Improved cellular differentiation and growth coordination
+ Activation of regenerative signaling pathways necessary for complex tissue and limb regrowth
We see Fetuin B activation as a promising molecular target that could one day help humans regenerate lost or damaged limbs and organs.
Our Research Approach
We are focusing on the discovery of novel Fetuin B activators using our proprietary platform:
High-Throughput Screening (HTS)
for Small-Molecule Activators
Using our advanced GFP-based promoter-reporter assays in human cell cultures, we screen thousands of natural and synthetic compounds to identify potent activators of Fetuin B gene expression.
This platform allows us to discover promising nutraceutical or pharmaceutical candidates capable of stimulating regenerative pathways.
Partnership Opportunities
We offer licensing of discovered compounds, custom research, and technology transfer for all three approaches.
HTS Screening Project: Start at $40,000 – $150,000 + 5% royalty
Gene Therapy Development: Custom pricing (typically $1M – $2M) + 5% royalty
Full technology transfer and offshore lab setup available
Head Office
Tampa
Florida, US
Call Now
312-730-2562
786-307-1256
Email Us
dr.nikolic@ufl.edu